Ahammune Biosciences announces first-in-human studies for new vitiligo drug in partnership with Veeda Clinical Research Read more
GSK announces £1 billion R&D investment over ten years to get ahead of infectious diseases in lower-income countries Read more
DCGI panel to review today SII applications for Covovax’s use among kids aged 2-7 years, 7-11 years Read more
Biological E gets WHO nod to be additional facility for making Johnson & Johnson COVID vaccine Read more